-
Sector Analysis
NewHER2-Positive Breast Cancer Epidemiology Analysis and Forecast to 2033
Breast cancer (International Classification of Diseases, 10th Revision [ICD-10] codes C50.0–50.9) is a malignant tumor that originates in the breast tissue. Breast cancer cells begin inside the milk ducts of the breast. The earliest form (in situ) is not life-threatening and can be detected in early stages. The most common type of non-invasive (stage 0) types of breast cancer is called ductal carcinoma in situ (DCIS) (American Cancer Society, 2022; World Health Organization, 2024). DCIS refers to abnormal cells that...
-
Thematic Analysis
NewInsurance M&A Deals, Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Insurance Sector
-
Thematic Analysis
NewBanking and Payments M&A Deals, Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Banking & Payments Sector
-
Sector Analysis
NewNorway Cards and Payments – Opportunities and Risks to 2027
Norway Cards and Payments Market Report Overview The annual value of card transactions in the Norway cards and payments market was $121.1 billion in 2023. The value is expected to grow at a CAGR of more than 6% during 2023-2027. The government’s substantial investments in building long-term infrastructure for cashless transactions are driving the gradual rise in the popularity of electronic payments. Moreover, factors such as affordable and widely available financial products, the growing presence of digital-only banks, and consumer...
-
Product Insights
NewLikelihood of Approval Analysis for Non-Small Cell Lung Carcinoma
Overview How likely is it that the drugs in Non-Small Cell Lung Carcinoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Non-Small Cell Lung Carcinoma Overview Non-small cell lung carcinoma (NSCLC)...
-
Product Insights
NewLikelihood of Approval Analysis for Obesity
Overview How likely is it that the drugs in Obesity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Obesity Overview Obesity, a complex medical condition characterized by excessive body fat accumulation,...
-
Analyst Opinions
NewData Center Construction Project Insights and Analytics (Q1 2024)
Data Center Construction Project Report Overview The data center construction projects value was $510.7 billion in Q1 2024. Data centres have earned the status of being the fifth utility, alongside water, electricity, gas, and telecoms due to their critical role in modern society. Rising incomes and technological advancement are driving the data traffic increase. Likewise, with the rise in global data traffic over the next decade, investment in data centre construction is expected to increase significantly. The data center construction...
-
Thematic Analysis
Inflation in Medical Devices – Thematic Intelligence
Inflation in Medical Devices Thematic Report Overview Even though COVID-19 vaccines and testing allowed economies and societies to safely reopen, supply-demand imbalance, inflation, recession prospects, market volatility, and geopolitical tensions and conflicts inject instability into the economic recovery and growth prospects. According to GlobalData’s Inflation Impact on the Healthcare Industry Survey (H2 2023), inflation, geopolitical conflicts, and reimbursement constraints may have the greatest negative impact on the medical device industry in 2024. These will have a reciprocal impact on healthcare...
-
Thematic Analysis
NewGlobal M&A Deals in Q1 2024 – Top Themes by Sector – Thematic intelligence
The global M&A market in Q1 2024 witnessed deals worth $613 billion, a rise of 38% compared to Q1 2024. In terms of deal volume, there was a 13% fall from 8,468 deals in Q1 2023 to 7,248 M&A deals in Q1 2024. The TMT sector led the M&A deal activity, with 2,163 deals worth $186 billion recorded in Q1 2024. Most sectors saw a year-on-year increase in deal activity in Q1 2024. Mega-deals (defined as any deal valued at...